Capricor Therapeutics, Inc.
CAPR
$29.96
$23.60371.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -7.66% | 16.56% | |||
| Gross Profit | 7.66% | -16.56% | |||
| SG&A Expenses | 4.46% | -6.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.18% | 10.95% | |||
| Operating Income | 5.18% | -10.95% | |||
| Income Before Tax | 5.17% | -6.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.17% | -6.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.17% | -6.23% | |||
| EBIT | 5.18% | -10.95% | |||
| EBITDA | 5.30% | -10.80% | |||
| EPS Basic | 5.19% | -6.06% | |||
| Normalized Basic EPS | 5.22% | -6.72% | |||
| EPS Diluted | 5.19% | -6.06% | |||
| Normalized Diluted EPS | 5.22% | -6.72% | |||
| Average Basic Shares Outstanding | 0.02% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||